These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 10830083)

  • 1. [Cardiac insufficiency: what treatment? what dose? For which patients? Converting enzyme inhibitors and diuretics].
    Komajda M
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():13-6. PubMed ID: 10830083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modern therapy of cardiac insufficiency].
    Stojsić D; Jelkić N
    Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Classic treatment of chronic heart insufficiency. What if new?].
    Aumont MC; Agnola D; Juliard JM; Karrillon G
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):599-602. PubMed ID: 7487308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone in severe heart failure: enhances efficacy of diuretic + ACE inhibitor combinations.
    Prescrire Int; 2000 Oct; 9(49):158-9. PubMed ID: 11603418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of cardiac failure with angiotensin-converting enzyme inhibitors and diuretics].
    Deray G; Martinez F; Jacobs C
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):735-40. PubMed ID: 8760660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
    Chow MS
    Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacologic treatment of chronic congestive heart failure].
    Halawa B
    Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors in congestive heart failure.
    Deedwania PC
    Arch Intern Med; 1990 Sep; 150(9):1798-805. PubMed ID: 2132302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of the treatment with converting enzyme inhibitors in chronic heart failure].
    Zannad F
    Rev Prat; 1992 Dec; 42(20):2563-7. PubMed ID: 1299941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of angiotensin-converting enzyme inhibitors in the treatment of heart failure in the 21st century].
    Gibelin P
    Arch Mal Coeur Vaiss; 2002 Feb; 95 Spec 4(5 Spec 4):41-5. PubMed ID: 11933555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Converting enzyme inhibitors and aims of the objectives of the treatment of cardiac failure].
    Komajda M
    Rev Prat; 1992 Dec; 42(20):2557-61. PubMed ID: 1299940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year.
    Houpe D; Peltier M; Cohen-Solal A; Béguin M; Lévy F; Slama M; Chapelain K; Tribouilloy C
    Int J Cardiol; 2005 Sep; 103(3):286-92. PubMed ID: 16098391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors in left ventricular dysfunction.
    Linn WD
    Pharmacotherapy; 1996; 16(2 Pt 2):50S-58S. PubMed ID: 8668606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin and angiotensin converting enzyme inhibitors in chronic heart failure.
    Gheorghiade M
    Can J Cardiol; 1990 Aug; 6 Suppl C():14C-17C. PubMed ID: 2205342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.